Covid-19 Update

Jonathan Ashworth Excerpts

Monday 7th June 2021 Commons Chamber

[Jonathan Ashworth (Leicester South) (Lab/Co-op)]

I am grateful to the Secretary of State for advance sight of his statement. I am also grateful that he has confirmed that the Government’s approach continues to be driven by the data, not by dates. We face some uncertainty, as we often have done throughout the past 15 months, but we do know that the delta variant is now the dominant variant in the UK. We know that 73% of delta cases are in unvaccinated people. We know that one dose offers less protection against this particular variant, and we know that, although hospitalisations are low, an increase in hospitalisations will put significant pressures on the NHS as it tries to deal with the care backlog. We also know, of course, that long covid is significant and debilitating for many people.

I am an optimist and I strongly believe that, ultimately, vaccination is our way through this. Can the Secretary of State go further on vaccination? Is he able to do more to drive up vaccination rates in those areas that have seen the delta variant take off and where uptake remains low, such as Blackburn or my own city of Leicester? Can he narrow the timeframe between the first and second dose, given that we know that one dose is not as protective as we would like? We have seen that Wales will be vaccinating everyone over 18 from next week. Can he tell us when England will follow?

Yesterday, the Secretary of State talked about the outbreaks among schoolchildren and young people. We know that children can transmit the virus and that children can be at particular risk of long covid. In that context, may I ask again why mask wearing is no longer mandatory in secondary schools? I am pleased that he has asked the JCVI to look at vaccination for children; it is something that I have I pressed him on a number of times at the Dispatch Box. Can he give us a timeframe on when he expects the JCVI to report on that front?

The Secretary of State talks about the G7. The pandemic has certainly shown that in an interconnected world where climate change and biodiversity loss drive zoonotic spillovers, working internationally to prevent future outbreaks is in our interests. None of us is safe until all of us are safe. That is not a slogan; it is the fact of the situation that we are in. That means working internationally. For a start, it means not cutting international aid, but it also means working globally on our vaccination efforts. He will have seen today that Gordon Brown, Tony Blair and other ex-world leaders have put forward a G7 burden sharing plan that would vaccinate the world. Will the Government support it?

Finally, I welcome what the Secretary of State said about research. Research and science are our way through this pandemic, and our way through to curing so many other diseases and ailments. However, he will know that while we are in this pandemic—while GPs and frontline staff are stretched—patients are unaware that a whole load of GP-held patient data is about to be transferred to NHS Digital.

Now, I am not opposed to NHS data being used for public good research, but some of the most sensitive personal data shared with GPs by patients in confidence several years ago—potentially when in a state of vulnerability, such as termination of pregnancy, matters of domestic or sexual abuse and issues of substance misuse or alcohol abuse—is set to be shared with NHS Digital and potentially to be used by commercial interests, and yet hardly anyone knows about it. There are worries about safeguards and patient confidentiality. Given the secrecy, the haste and the difficulties in opting out, will the Secretary of State now consider abandoning this plan, pausing it for now and launching a transparent consultation process with patients and clinicians on how confidential data can best be shared for research purposes?

[Matt Hancock]

First, the right hon. Gentleman raised the question of ensuring that we reduce transmission among children. It is true that the increase in case rates has predominantly been among children, especially secondary school-aged children. The testing regime among secondary school-aged children has been enthusiastically taken up by schools across the country. It is very important, as we return from half-term, that that is reinstated in full—that every child is being tested twice a week. It made a big difference in helping to keep schools open. If somebody tested positive at home before they went in, it meant that the whole bubble did not have to go home. It also prevented transmission up to older people, who might be more badly affected. Testing in schools is incredibly important to ensure that we can keep as much education as possible between now and the summer.

The right hon. Gentleman asked about the JCVI advice on children’s vaccination that will be available in a matter of weeks. I know that the JCVI is working hard on it now. I will of course come to the House, Mr Speaker, to explain the proposed approach as soon as we have that formal advice.

Finally, the right hon. Gentleman asked about the use of patient data. I am glad that he said how important he thought research based on data is within the NHS, because it is life-saving. It has been used incredibly powerfully during the pandemic. In fact, one of the reasons why the UK is the place where we discovered some of the life-saving treatments for covid, such as dexamethasone, is the powerful use of data. Just that discovery of dexamethasone, which happened through the use of NHS data, has saved over 1 million lives around the world.

The right hon. Gentleman raised the issue of data, which he said belonged to GPs, being passed to NHS Digital. The truth is that data about his, my or anybody else’s medical condition does not belong to any GP; it belongs, rightly, to the citizen—the patient. That is the approach that we should take. I absolutely agree that it is important to do these things right and properly, but I am also very glad that the vast majority of people are strongly on side for the use of their data to improve lives and save lives. That is the approach that we are going to take in building a modern data platform for the NHS, so that we can ensure that we use this modern asset to improve individuals’ care and to improve research and therefore all our care, while of course preserving the highest standards of safety and privacy, which will be enhanced by a more modern use of data. I am glad that he is on side for the use of data in the NHS, but you have to be on side when that is actually put into practice. It is not just warm words; it is about making it happen.